Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
3.070
-0.070 (-2.23%)
At close: May 28, 2025, 4:00 PM
3.070
0.00 (0.00%)
After-hours: May 28, 2025, 4:10 PM EDT
Myomo Revenue
Myomo had revenue of $9.83M in the quarter ending March 31, 2025, with 161.88% growth. This brings the company's revenue in the last twelve months to $38.63M, up 97.60% year-over-year. In the year 2024, Myomo had annual revenue of $32.55M with 69.17% growth.
Revenue (ttm)
$38.63M
Revenue Growth
+97.60%
P/S Ratio
2.74
Revenue / Employee
$208,803
Employees
185
Market Cap
110.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MYO News
- 20 days ago - Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Myomo Reports First Quarter 2025 Financial and Operating Results - Business Wire
- 27 days ago - Myomo to Host Investor & Analyst Day Event on June 18, 2025 - Business Wire
- 4 weeks ago - Myomo to Report First Quarter 2025 Financial Results on May 7 - Business Wire
- 4 weeks ago - Myomo Launches the MyoPro® 2x - Business Wire
- 6 weeks ago - Myomo Announces Upcoming Changes to its Board of Directors - Business Wire
- 2 months ago - Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript - Seeking Alpha